DROXIA 6335 DROXIA 6335 (Droxia 200 mg)
Generic Name: hydroxyurea
Pill imprint DROXIA 6335 DROXIA 6335 has been identified as Droxia 200 mg.
Droxia is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for DROXIA 6335 DROXIA 6335 (Droxia 200 mg)
Droxia
- Generic Name:
- hydroxyurea
- Imprint:
-
DROXIA 6335
DROXIA 6335 - Strength:
- 200 mg
- Color:
- Green
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-6335
- Inactive Ingredients:
- citric acid
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
FD&C Blue No. 1
FD&C Green No. 3
More resources
Droxia is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
